Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DiaSorin AB
AB
Active
Org 5561693440
Solna Torg 19, 171 45
Solna
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1972 · 53 years old
17 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
DiaSorin AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
228M
171M
114M
57M
0M
2020: 62M
62M
2020
2021: 145M (+134% vs 2020)
145M
+134%
2021
2022: 156M (+8% vs 2021)
156M
+8%
2022
2023: 179M (+15% vs 2022)
179M
+15%
2023
2024: 183M (+2% vs 2023)
183M
+2%
2024
EBITDA
SEK millions
11M
8M
6M
3M
0M
2020: 3M
3M
2020
2021: 5M (+67% vs 2020)
5M
+67%
2021
2022: 9M (+80% vs 2021)
9M
+80%
2022
2023: 6M (-33% vs 2022)
6M
-33%
2023
2024: 8M (+33% vs 2023)
8M
+33%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
182 868
179 206
155 986
145 170
62 237
Staff expenses
—
—
—
—
—
EBITDA
7 595
6 365
9 016
5 369
3 393
Depreciation & amort.
—
—
—
—
—
EBIT
7 595
6 365
9 016
5 369
3 393
Net financials
1 963
714
4 368
1 045
−3 097
Profit before tax
9 758
7 079
13 384
6 414
3 959
Tax
−2 317
−1 550
−2 590
−1 508
−1 470
Net profit
7 441
5 529
10 794
4 906
2 489
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
117 848
118 646
106 315
83 859
87 385
Equity
39 225
36 284
39 256
28 586
23 730
Long-term debt
0
0
0
0
0
Short-term debt
60 115
64 075
50 581
38 053
45 887
Total debt
60 115
64 075
50 581
38 053
45 887
Financial ratios
5-year trend
EBITDA margin
4,2 %
This company
15,8 %
Market median
This company
Market median
73% below market
2020
2024
Equity ratio
33,3 %
This company
38,2 %
Market median
This company
Market median
13% below market
2020
2024
Return on equity
19,0 %
This company
18,4 %
Market median
This company
Market median
3% above market
2020
2024
Net profit margin
4,1 %
This company
8,1 %
Market median
This company
Market median
49% below market
2020
2024
Asset turnover
1,55×
This company
1,12×
Market median
This company
Market median
38% above market
2020
2024
Debt / equity
2,00×
This company
0,62×
Market median
This company
Market median
223% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on DiaSorin AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
